17:55 EST Novo Nordisk (NVO) says Wegovy pill approved in U.S. as oral GLP-1, Bloomberg reports
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Moderately bullish activity in Novo Nordisk with shareslittle changed
- Novo Nordisk call volume above normal and directionally bullish
- Mixed options sentiment in Novo Nordisk with shares up 1.27%
- Mixed options sentiment in Novo Nordisk with shares down 0.22%
- Eli Lilly (LLY) Says Obesity Pill Helps Maintain Weight Loss as Patients Switch from Zepbound